Page last updated: 2024-08-16

resveratrol and Cystic Fibrosis

resveratrol has been researched along with Cystic Fibrosis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Alfano, AI; Barone, S; Brindisi, M; Cassese, E; Summa, V1
Corey, DA; Kelley, TJ; Lu, B1
Bradbury, NA; Bridges, RJ; Jai, Y; Shah, K1
Badmaev, V; Hanania, N; Lan, C; Sharafkhaneh, A; Velamuri, S1
Burgess, JD; Fang, D; Jiang, D; Kelley, TJ; Manson, ME; Previs, SF; Ruddy, J; Sonawane, ND; West, RH1
Aissat, A; Baudoin-Legros, M; Colas, J; Edelman, A; Fritsch, J; Hamdaoui, N; Kelly, M; Moriceau, S; Planelles, G; Vieu, DL1

Reviews

2 review(s) available for resveratrol and Cystic Fibrosis

ArticleYear
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.
    Journal of medicinal chemistry, 2022, 02-24, Volume: 65, Issue:4

    Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Histone Deacetylase 6; Humans; Signal Transduction

2022
The potential role of natural agents in treatment of airway inflammation.
    Therapeutic advances in respiratory disease, 2007, Volume: 1, Issue:2

    Topics: Ambroxol; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Cystic Fibrosis; Diet; Expectorants; Humans; Justicia; Lung Diseases, Obstructive; Phytotherapy; Picrorhiza; Pneumonia; Prostaglandins; Resveratrol; Stilbenes; Treatment Outcome; Tylophora

2007

Other Studies

5 other study(ies) available for resveratrol and Cystic Fibrosis

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Resveratrol restores intracellular transport in cystic fibrosis epithelial cells.
    American journal of physiology. Lung cellular and molecular physiology, 2020, 06-01, Volume: 318, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; Acetylation; Biological Transport; Carbazoles; Cells, Cultured; Cholesterol; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Humans; Intracellular Space; Microtubules; Nose; Phosphodiesterase Inhibitors; PPAR gamma; Resorcinols; Resveratrol; Signal Transduction; Sirtuins; Stilbenes; Tubulin

2020
Evidence against resveratrol as a viable therapy for the rescue of defective ΔF508 CFTR.
    Biochimica et biophysica acta, 2015, Volume: 1850, Issue:11

    Topics: Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; HEK293 Cells; Humans; Mutation; Resveratrol; Stilbenes

2015
Increased plasma membrane cholesterol in cystic fibrosis cells correlates with CFTR genotype and depends on de novo cholesterol synthesis.
    Respiratory research, 2010, May-20, Volume: 11

    Topics: Animals; Benzoates; Binding Sites; Cell Line; Cell Membrane; Cholesterol; Cholesterol Oxidase; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Electrochemical Techniques; Epithelial Cells; Genotype; Humans; Hydroxymethylglutaryl-CoA Synthase; Kinetics; Mass Spectrometry; Mice; Mice, Inbred CFTR; Microelectrodes; Mutation; Nasal Mucosa; Phenotype; Promoter Regions, Genetic; Respiratory Mucosa; Resveratrol; Stilbenes; Thiazolidines; Transfection

2010
Resveratrol rescues cAMP-dependent anionic transport in the cystic fibrosis pancreatic cell line CFPAC1.
    British journal of pharmacology, 2011, Volume: 163, Issue:4

    Topics: Animals; Anion Transport Proteins; Biological Transport; Cell Line; Cell Line, Tumor; Cell Membrane; Chloride Channels; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dogs; Epithelial Cells; Humans; Interleukin-8; Mutation; Resveratrol; Stilbenes

2011